Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer.

Trial Profile

Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jul 2012

At a glance

  • Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Gallbladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2012 Actual end date (1 May 2012) added as reported by University Hospital Medical Information Network - Japan.
    • 01 May 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 14 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top